This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_ALL_EXALLC for full statistics.
Acute lymphocytic leukaemia
C3_ALL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
237 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
237 |
4. Check minimum number of eventsNone |
237 |
5. Include endpoints |
237 |
6. Filter based on genotype QC (FinnGen only) |
237 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Acute lymphocytic leukaemia
based on the number of shared cases.
Similar with more cases:
- Acute lymphocytic leukaemia, helper endpoint
- Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)
- Any event in cancer register
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 237 | 132 | 105 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.05 |
| Median age at first event (years) | 9.23 | 6.99 | 12.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 237
- Matched controls
- 2371
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3260.0
291.8
229
20
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
13656.8
266.5
204
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
237.2
186
*
L01BB02
ATC
mercaptopurine; oral
304.4
161.4
149
13
TAB00
NOMESCO Finland
Lumbar puncture
62.8
119.3
139
52
H02AB02
ATC
dexamethasone; systemic
45.0
101.8
128
60
H02AB09
ATC
hydrocortisone; systemic
51.1
92.2
111
40
XW000
NOMESCO Finland
Bone marrow biopsy
61.6
91.1
105
30
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
65.2
89.5
102
27
Z85.6
ICD-10 Finland
Personal history of leukaemia
1042.7
79.1
73
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
20.8
66.2
105
87
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
62.6
62.0
71
16
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
231.7
54.5
54
*
2040A
ICD-9 Finland
Lymphoid leukaemia, Acute
609.6
51.5
49
*
L03AA02
ATC
filgrastim; parenteral
46.1
51.1
62
18
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
50.9
47
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
45.3
42
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
26.4
44.9
63
32
ZX131
NOMESCO Finland
Intrathecal
+∞
41.9
39
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
27.8
40.7
56
26
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
14.0
38.8
70
69
A04AA01
ATC
ondansetron; systemic, rectal
12.6
33.6
63
66
A41.9
ICD-10 Finland
Sepsis, unspecified
20.1
32.9
50
31
R50.9
ICD-10 Finland
Fever, unspecified
6.5
32.8
103
250
127
Kela drug reimbursment
Transplant complication
35.1
32.0
41
14
H02AB06
ATC
prednisolone; systemic
5.1
30.7
148
581
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
17.9
30.4
48
33
J05AB11
ATC
valaciclovir; oral
8.0
30.1
75
129
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
9.4
29.9
66
93
WW500
NOMESCO Finland
Blood transfusion
15.2
29.5
50
41
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
118.3
29.4
31
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
118.3
29.4
31
*
20400
ICD-8 Finland
Lymphatic leukaemia, Acute
+∞
28.7
27
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
316.9
28.4
28
*
9101
FHL
Bone biopsy
+∞
27.6
26
*
A05AA02
ATC
ursodeoxycholic acid; oral
29.0
27.6
37
15
J02AC01
ATC
fluconazole; systemic
4.7
26.8
128
475
1XX02
NOMESCO Finland
NA
+∞
26.6
25
*
ZX114
NOMESCO Finland
Intramuscular
29.1
26.2
35
14
K03.66
ICD-10 Finland
Tooth plaque
6.6
24.8
71
145
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
241.4
22.0
22
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.7
21.5
68
155
M04AA01
ATC
allopurinol; systemic
9.1
19.4
42
55
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.2
19.4
32
24
ZX121
NOMESCO Finland
Central venous catheter
37.9
19.3
24
7
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
27.7
18.6
25
10
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.4
18.4
77
233
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
14.8
18.0
30
23
2301
FHL
Lumbar puncture in anesthesia or operating room
+∞
17.9
17
*
A06AD11
ATC
lactulose; oral
6.1
17.9
52
105
121
Kela drug reimbursment
Severe hypofunction of sexual glands
20.7
17.8
26
14
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
193.9
17.8
18
*
J05AB01
ATC
aciclovir; systemic
4.3
17.5
75
231
L03AA10
ATC
lenograstim; parenteral
+∞
16.9
16
*
ZX120
NOMESCO Finland
Intravenous
6.3
16.8
47
90
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.6
16.3
91
346
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.0
16.1
74
241
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
15.7
69
215
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
20.0
15.0
22
12
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
85.5
14.8
16
*
L01BB03
ATC
tioguanine; oral
+∞
14.7
14
*
9109
FHL
Other measure in this category
+∞
14.7
14
*
602
Kela drug reimbursment
Children's severe malnutrition
15.8
14.4
23
16
A01AB09
ATC
miconazole; local oral
5.8
14.3
42
85
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
14.8
14.1
23
17
XF400
NOMESCO Finland
ECG with 12 standard connections
3.8
13.8
66
219
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
13.8
105
491
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
36.4
13.7
17
5
2AX04
NOMESCO Finland
NA
+∞
13.7
13
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
148.1
13.6
14
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.9
13.4
115
581
J01MA12
ATC
levofloxacin; systemic
4.5
13.3
50
133
L04AA06
ATC
mycophenolic acid; systemic
16.7
12.9
20
13
ZXA00
NOMESCO Finland
Right side
3.5
12.8
69
251
0388X
ICD-9 Finland
Septicaemia, Other specified septicaemias
+∞
12.6
12
*
J02AC03
ATC
voriconazole; systemic
+∞
12.6
12
*
A02BC01
ATC
omeprazole; systemic
3.3
12.6
74
285
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
39.8
12.4
15
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
68.4
11.7
13
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.3
11.7
45
122
A04AA02
ATC
granisetron; systemic, transdermal
9.1
11.6
24
29
Z92.6
ICD-10 Finland
Personal history of chemotherapy for neoplastic disease
+∞
11.5
11
*
L01XE06
ATC
[U] dasatinib; systemic
+∞
11.5
11
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
11.5
11
*
FM2CE
NOMESCO Finland
NA
7.1
11.5
28
44
R4110
NOMESCO Finland
Physiotherapy
3.0
11.5
81
353
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.5
11.4
34
70
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
26.5
11.3
15
6
ZX090
NOMESCO Finland
Other technic of radiotherapy
14.9
11.2
18
13
D70.89
ICD-10 Finland
Neutropenic splenomegaly
12.8
11.1
19
16
L04AA01
ATC
[U] ciclosporin; systemic
13.8
10.8
18
14
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
62.9
10.7
12
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.4
10.7
25
37
D64.9
ICD-10 Finland
Anaemia, unspecified
5.4
10.6
32
67
150
Kela drug reimbursment
Dasatinib
+∞
10.5
10
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
10.5
10
*
J02AC04
ATC
posaconazole; systemic
+∞
10.5
10
*
1CX01
NOMESCO Finland
NA
+∞
10.5
10
*
A01AB04
ATC
amphotericin B; local oral
11.4
10.5
19
18
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.7
10.3
26
43
ZX108
NOMESCO Finland
Inhalation
14.2
9.8
16
12
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.7
9.8
22
31
WW409
NOMESCO Finland
Other aferesis
57.4
9.7
11
*
K02.0
ICD-10 Finland
Caries limited to enamel
2.8
9.7
74
333
B73
ICPC
Leukaemia
104.0
9.5
10
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
9.4
9
*
2AA01
NOMESCO Finland
NA
+∞
9.4
9
*
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
7.6
9.3
21
30
L04AD01
ATC
ciclosporin; systemic
8.2
8.8
19
25
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
52.0
8.7
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
8.6
81
406
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
5.8
8.1
22
41
C90.0
ICD-10 Finland
Multiple myeloma
15.7
7.8
12
8
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
46.5
7.8
9
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.6
7.7
19
31
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
19.1
7.7
11
6
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
12.4
7.7
13
11
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
7.6
102
602
5639
FHL
Other measure in this category
82.6
7.5
8
*
Z08.2
ICD-10 Finland
Follow-up examination after chemotherapy for malignant neoplasm
82.6
7.5
8
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
82.6
7.5
8
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
82.6
7.5
8
*
N02AA05
ATC
oxycodone; systemic
3.7
7.3
32
97
M87.3
ICD-10 Finland
Other secondary osteonecrosis
+∞
7.3
7
*
5604
FHL
Vascular preparation or cannulation in the operating room
31.0
7.2
9
*
ZXA10
NOMESCO Finland
Bilateral
2.8
7.2
50
208
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
7.0
55
246
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
14.3
7.0
11
8
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
17.3
6.8
10
6
1AB02
NOMESCO Finland
NA
41.3
6.8
8
*
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
41.3
6.8
8
*
GD1LA
NOMESCO Finland
GD
23.3
6.7
9
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
12.7
6.6
11
9
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
9.1
6.6
13
15
A07AA02
ATC
nystatin; oral
4.7
6.5
21
48
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.5
6.5
18
35
6BA02
NOMESCO Finland
NA
71.7
6.5
7
*
189
Kela drug reimbursment
Imatinib
71.7
6.5
7
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
8.5
6.4
13
16
Z31.6
ICD-10 Finland
General counselling and advice on procreation
9.7
6.4
12
13
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
6.4
131
902
IEP04
NOMESCO Finland
Focused parenting intervention
18.6
6.3
9
5
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
6.3
6
*
L01AA01
ATC
cyclophosphamide; systemic
+∞
6.3
6
*
B28
ICPC
Limited function/disability (B)
+∞
6.3
6
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
+∞
6.3
6
*
324
Kela drug reimbursment
Dasatinib
+∞
6.3
6
*
ZXA05
NOMESCO Finland
Left side
2.5
6.2
50
227
JN4BD
NOMESCO Finland
Extensive body CT
3.8
6.1
25
72
B02.9
ICD-10 Finland
Zoster without complication
4.8
6.1
19
42
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
6.0
117
782
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
6.0
56
273
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
50
60
10.29
40.14
13.3
1.9
10.0
6.4
e6/l
0.16
45
52
50
60
10.29
40.14
13.3
2.0
29.1
86.7
e6/l
0.84
45
54
37
28
15.47
40.02
6.4
2.3
6.6
9.7
%
1.12
27
21
41
37
13.19
39.98
4.4
1.6
—
—
—
0
0
35
25
16.25
39.04
8.1
2.0
0.1
0.2
e9/l
1.05
27
19
34
24
16.37
38.13
3.4
1.7
—
—
—
0
0
40
5
95.35
37.12
23.8
30.4
0.4
0.5
umol/l
—
40
5
65
118
7.21
36.58
2.9
2.0
8.4
15.0
iu/l
1.64
50
98
34
26
15.10
36.46
8.3
2.0
663.8
545.4
e6/l
0.40
26
19
42
45
11.13
36.46
5.0
1.7
—
—
—
0
0
42
46
10.88
35.88
4.4
1.6
—
—
—
0
0
34
27
14.53
35.67
3.3
1.7
—
—
—
0
0
39
40
11.47
34.84
17.2
8.2
326.2
457.2
iu/ml
—
10
5
64
122
6.82
34.21
3.0
2.0
6.8
8.0
u/l
0.34
46
98
32
26
14.07
33.05
6.9
2.4
—
—
—
0
0
34
36
10.86
29.56
2.9
3.7
3.2
3.7
e9/l
0.59
34
36
34
36
10.86
29.56
3.9
3.8
51.5
52.8
%
0.21
34
36
27
22
13.72
27.70
7.6
1.9
34.6
24.3
%
2.13
27
22
32
38
9.58
25.50
4.6
1.8
—
—
—
0
0
43
76
6.69
24.34
1.6
1.6
—
—
—
0
0
47
94
5.99
23.46
20.0
4.3
87.1
92.7
%
0.83
47
94
27
6
50.51
22.90
1.2
1.0
—
—
—
0
0
26
5
58.08
22.59
1.5
2.0
—
—
—
0
0
40
76
6.13
20.96
1.9
1.6
97.4
97.5
u/ml
—
8
11
43
90
5.62
20.33
1.6
1.8
—
—
—
0
0
57
154
4.56
19.94
3.2
1.6
—
—
—
0
0
57
157
4.46
19.42
3.3
1.7
—
—
—
0
0
41
87
5.49
19.05
1.5
1.8
114.7
165.3
u/ml
1.12
28
46
64
197
4.08
18.76
13.9
4.3
4.4
8.0
umol/l
1.53
56
164
30
49
6.86
18.14
1.7
1.5
0.3
0.4
nmol/l
0.45
23
40
24
31
8.50
17.75
4.2
1.3
—
—
—
0
0
21
23
9.92
17.58
4.7
1.4
—
—
—
0
0
15
10
15.95
16.90
6.9
2.0
—
—
—
0
0
15
10
15.95
16.90
6.9
2.0
—
—
—
0
0
25
37
7.44
16.48
2.9
1.2
—
—
—
0
0
64
217
3.67
16.12
4.4
1.8
—
—
—
0
0
71
278
3.22
14.06
3.0
3.8
623.2
1011.1
ng/l
0.89
58
228
38
98
4.43
13.87
4.4
1.6
—
—
—
0
0
15
15
10.61
13.26
1.2
1.1
—
—
—
0
0
18
24
8.03
12.88
2.7
1.1
—
—
—
0
0
110
586
2.64
11.96
16.8
6.2
35.4
37.2
g/l
2.33
104
556
82
377
2.80
11.95
11.8
2.3
1.8
1.0
mg/l
1.16
67
275
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
34
6.33
11.53
8.7
8.5
0.3
0.4
u/ml
0.90
14
24
168
1112
2.75
11.50
56.8
9.6
2.9
3.9
e9/l
10.96
159
966
16
22
7.73
11.12
1.6
1.6
—
—
—
0
0
51
193
3.09
10.46
1.7
3.0
25.6
23.2
%
0.44
46
181
42
142
3.38
10.36
3.7
2.1
13.0
12.7
nmol/l
0.06
34
126
13
15
9.11
10.33
6.6
1.7
33.9
32.7
pg
0.43
13
15
129
780
2.43
10.26
27.7
8.6
1.2
1.2
mmol/l
0.38
111
690
21
43
5.26
9.99
2.3
1.2
—
—
—
0
0
21
43
5.26
9.99
2.3
1.2
—
—
—
0
0
120
713
2.38
9.80
27.1
8.5
1.2
1.2
mmol/l
0.26
115
662
144
930
2.40
9.66
18.0
5.5
6.1
6.5
mmol/l
1.28
137
842
53
224
2.76
8.81
3.5
2.3
339.1
378.7
nmol/l
0.85
53
213
13
8
17.09
8.65
1.9
1.0
—
—
—
0
0
8
0
+∞
8.38
11.4
0.0
—
—
—
0
0
95
555
2.19
7.61
12.7
3.1
31.6
31.3
u/l
0.04
95
535
11
8
14.34
6.96
5.9
2.5
—
—
—
0
0
13
24
5.67
6.85
5.8
2.1
—
—
—
0
0
11
9
12.74
6.65
8.0
5.2
—
—
—
0
0
10
15
6.92
6.36
2.9
1.4
—
—
—
0
0
6
0
+∞
6.27
1.0
0.0
—
—
—
0
0
6
0
+∞
6.27
12.2
0.0
—
—
—
0
0
6
0
+∞
6.27
4.0
0.0
—
—
—
0
0
10
16
6.48
6.00
1.6
1.0
—
—
—
0
0
69
388
2.10
5.86
11.3
2.3
—
—
—
0
0
10
9
11.53
5.85
1.3
1.0
—
—
—
0
0
94
597
1.95
5.66
5.3
3.8
—
—
—
0
0
80
492
1.95
5.22
4.9
3.7
0.1
0.2
e6/l
0.26
67
374
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
23
4.97
5.06
1.4
1.1
—
—
—
0
0
12
29
4.31
4.68
1.2
1.6
—
—
—
0
0
7
5
14.36
4.60
10.6
2.0
—
—
—
0
0
18
62
3.06
4.27
2.4
1.6
—
—
—
0
0
38
195
2.13
4.01
42.9
7.1
24.3
23.7
mmol/l
1.01
38
190
69
437
1.82
3.97
2.1
2.9
2.5
2.8
mg/l
0.64
61
379
12
33
3.78
3.97
1.6
1.6
—
—
—
0
0
10
24
4.31
3.93
1.1
1.5
—
—
—
0
0
7
8
8.97
3.80
5.3
7.0
—
—
—
0
0
7
8
8.97
3.80
5.3
6.9
—
—
—
0
0
6
5
12.26
3.78
5.0
1.2
—
—
—
0
0
6
5
12.26
3.78
5.0
1.2
—
—
—
0
0
28
130
2.31
3.75
1.9
1.6
353.9
312.7
mu/l
0.26
28
124
27
124
2.33
3.71
12.2
12.5
0.7
0.0
mmol/l
0.38
18
99
8
12
6.85
3.70
12.9
4.6
—
—
—
0
0
44
248
1.95
3.60
38.3
6.7
1.9
1.5
mmol/l
0.59
39
185
20
81
2.60
3.57
1.5
1.3
—
—
—
0
0
8
13
6.33
3.53
2.5
1.6
—
—
—
0
0
14
47
3.10
3.47
1.5
1.0
—
—
—
0
0
13
42
3.22
3.42
2.0
1.9
—
—
—
0
0
6
7
8.75
3.28
10.2
1.4
—
—
—
0
0
6
7
8.75
3.28
10.2
1.4
—
—
—
0
0
6
7
8.75
3.28
10.2
1.4
—
—
—
0
0
182
1552
1.74
3.24
3.9
3.5
2.7
2.8
mmol/l
0.18
177
1447
8
16
5.13
3.07
1.6
1.5
—
—
—
0
0
7
12
5.97
3.04
1.4
1.9
—
—
—
0
0
104
782
1.59
3.02
13.8
4.0
—
—
—
0
0
29
150
2.06
3.01
1.8
1.4
124.9
320.6
u/ml
0.60
24
140
5
5
10.17
2.99
5.8
1.2
—
—
—
0
0
5
5
10.17
2.99
5.8
1.2
—
—
—
0
0
5
5
10.17
2.99
1.2
1.0
—
—
—
0
0
9
22
4.21
2.91
1.4
1.1
—
—
—
0
0
6
9
6.80
2.88
10.5
1.4
—
—
—
0
0
6
9
6.80
2.88
10.5
1.4
—
—
—
0
0
6
9
6.80
2.88
10.5
1.4
—
—
—
0
0
6
9
6.80
2.88
10.5
1.4
—
—
—
0
0
6
9
6.80
2.88
4.5
9.9
—
—
—
0
0
152
1741
0.65
2.56
3.9
3.8
—
—
—
0
0
20
96
2.18
2.51
2.4
2.3
102.8
79.5
ml/min/173m2
—
8
43
47
302
1.69
2.51
4.3
3.4
0.7
0.7
e6/l
0.04
29
177
7
16
4.47
2.49
9.9
1.6
—
—
—
0
0
7
16
4.47
2.49
9.9
1.6
—
—
—
0
0
7
16
4.47
2.49
9.9
1.6
—
—
—
0
0
5
8
6.35
2.38
1.2
1.4
—
—
—
0
0
7
17
4.21
2.38
1.0
1.0
—
—
—
0
0
138
1145
1.49
2.35
5.5
4.2
83.7
24.5
e6/l
—
7
18
62
436
1.57
2.31
2.5
3.2
18.6
30.2
ng/l
0.90
40
236
6
13
4.70
2.28
2.0
3.9
73.8
149.6
ug/l
—
6
13
22
117
1.97
2.14
6.0
3.0
—
—
—
0
0
5
10
5.08
2.08
2.2
1.2
—
—
—
0
0
5
10
5.08
2.08
1.2
1.0
—
—
—
0
0
45
302
1.60
2.03
4.5
3.5
2.7
2.9
e6/l
0.07
26
177
9
32
2.88
2.02
5.1
1.3
—
—
—
0
0
171
1886
0.66
2.02
62.7
12.4
37.7
40.3
%
4.43
138
1585
39
564
0.63
1.88
2.1
2.5
—
—
—
0
0
18
94
1.99
1.86
6.3
4.0
1.2
1.2
mmol/l
0.37
18
83
33
210
1.66
1.83
7.5
6.6
1.6
1.0
mmol/l
0.92
26
152
37
245
1.60
1.77
3.3
3.5
135.8
764.9
ng/l
0.78
25
157
7
25
2.85
1.66
1.3
1.0
—
—
—
0
0
8
32
2.55
1.61
1.0
1.1
—
—
—
0
0
7
26
2.74
1.59
1.7
1.3
—
—
—
0
0
37
522
0.65
1.57
2.0
2.3
—
—
—
0
0
5
15
3.38
1.53
1.0
1.0
—
—
—
0
0
188
1721
1.45
1.50
62.6
14.1
13.7
13.3
%
4.14
188
1690
5
16
3.17
1.44
1.4
1.2
—
—
—
0
0
162
1451
1.37
1.43
23.0
9.0
100.7
96.7
ml/min/173m2
1.28
144
1092
7
29
2.46
1.40
1.0
1.1
—
—
—
0
0
5
17
2.98
1.36
8.4
1.4
—
—
—
0
0
204
1907
1.50
1.35
36.0
8.1
35.3
26.5
u/l
4.57
204
1847
85
697
1.34
1.34
2.2
1.8
—
—
—
0
0
5
18
2.81
1.29
8.4
1.3
—
—
—
0
0
5
18
2.81
1.29
8.4
1.3
—
—
—
0
0
5
18
2.81
1.29
8.4
1.3
—
—
—
0
0
5
18
2.81
1.29
8.4
1.3
—
—
—
0
0
5
18
2.81
1.29
8.4
1.3
—
—
—
0
0
27
183
1.54
1.20
8.5
6.8
24.9
24.3
mmol/l
1.06
27
178
208
2170
0.66
1.19
68.1
16.2
128.9
136.0
g/l
6.68
208
2142
11
196
0.54
1.19
1.5
1.4
—
—
—
0
0
14
81
1.77
1.11
1.1
1.5
—
—
—
0
0
5
22
2.30
1.04
1.2
1.6
—
—
—
0
0
7
34
2.09
1.03
1.1
1.9
—
—
—
0
0
13
77
1.73
0.97
20.5
10.8
95.2
94.4
%
0.40
13
77
13
78
1.71
0.93
20.5
10.6
0.8
0.7
%
0.48
13
78
6
28
2.17
0.92
1.2
1.1
—
—
—
0
0
13
79
1.68
0.90
20.5
10.5
1.6
1.4
%
0.20
13
79
6
29
2.10
0.90
1.0
1.1
—
—
—
0
0
56
459
1.29
0.86
3.5
3.5
0.0
0.0
estimate
0.50
17
171
60
504
1.26
0.76
2.0
1.7
104.0
95.6
pmol/l
0.51
34
261
5
24
2.11
0.75
1.2
1.7
—
—
—
0
0
21
283
0.72
0.72
1.1
1.3
1.1
6.9
u/ml
—
8
107
99
885
1.20
0.69
3.9
3.5
0.0
0.0
estimate
0.00
18
167
17
119
1.46
0.69
1.1
1.4
361.6
290.1
miu/ml
—
5
65
5
92
0.53
0.68
2.8
1.5
—
—
—
0
0
98
879
1.20
0.65
5.6
5.0
0.0
0.0
estimate
0.00
18
174
14
199
0.68
0.65
4.2
3.9
19.3
20.8
%
—
5
88
6
103
0.57
0.63
2.5
1.7
—
—
—
0
0
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
18
241
0.73
0.60
1.7
1.5
—
—
—
0
0
0
21
0.00
0.60
0.0
1.4
—
4.9
—
0
15
7
114
0.60
0.59
1.9
2.0
—
—
—
0
0
32
257
1.28
0.59
1.5
1.6
388.7
449.1
pmol/l
0.45
26
231
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
97
877
1.18
0.58
3.6
3.4
0.0
0.0
estimate
0.00
16
171
158
1493
1.17
0.53
4.6
3.2
5.6
5.7
mmol/l
0.11
153
1363
7
48
1.47
0.47
1.6
1.5
—
—
—
0
0
8
118
0.67
0.47
1.9
1.7
—
—
—
0
0
11
151
0.72
0.44
1.8
1.2
—
—
—
0
0
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
73
663
1.15
0.40
3.7
3.3
—
—
—
0
0
17
135
1.28
0.36
12.9
6.0
—
—
—
0
0
6
41
1.48
0.36
1.5
1.8
1.5
0.6
nmol/l
—
6
35
194
1891
1.14
0.30
46.6
11.1
18.3
21.7
mg/l
1.03
170
1388
7
55
1.28
0.30
1.1
1.9
—
—
—
0
0
9
117
0.76
0.28
1.4
1.4
—
—
—
0
0
9
117
0.76
0.28
1.4
1.4
—
—
—
0
0
9
117
0.76
0.28
1.4
1.4
—
—
—
0
0
9
117
0.76
0.28
1.4
1.4
—
—
—
0
0
15
181
0.82
0.26
1.1
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
3.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
6
48
1.26
0.20
5.2
3.4
23.6
23.7
mmol/l
—
6
42
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
6
49
1.23
0.20
14.3
2.2
—
—
—
0
0
6
50
1.21
0.20
1.3
1.2
—
—
—
0
0
6
50
1.21
0.20
2.0
1.6
—
—
—
0
0
30
330
0.90
0.18
2.0
2.0
—
—
—
0
0
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
20
177
1.14
0.17
2.3
2.4
24779.8
4344.7
u/l
—
6
72
11
129
0.85
0.15
1.5
1.5
—
—
—
0
0
9
83
1.09
0.15
1.1
1.4
—
—
—
0
0
20
179
1.13
0.14
1.2
1.2
182.8
133.9
iu/ml
0.31
12
69
5
45
1.11
0.10
1.0
1.1
—
13.8
—
0
7
30
282
1.07
0.09
1.1
1.3
10.0
29.5
iu/ml
—
6
83
5
63
0.79
0.08
2.4
1.0
—
—
—
0
0
5
65
0.76
0.08
2.4
1.0
—
—
—
0
0
12
132
0.90
0.07
2.6
1.8
—
—
—
0
0
66
647
1.03
0.04
1.4
1.6
0.7
2.1
u/ml
1.82
19
136
11
102
1.08
0.03
1.6
1.6
—
—
—
0
0
10
93
1.08
0.02
1.3
1.2
—
—
—
0
0
33
322
1.03
0.02
1.8
1.5
—
—
—
0
0
27
269
1.00
0.00
1.6
1.9
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
6
67
0.89
0.00
1.0
1.1
—
16.8
—
0
7
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
16.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
0.00
1.0
1.8
49.3
42.0
u/l
—
6
53
5
50
1.00
0.00
5.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
4.7
—
1.2
—
0
7
0
5
0.00
0.00
0.0
1.2
—
197.2
—
0
5
0
5
0.00
0.00
0.0
1.0
—
21.2
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
9
95
0.95
0.00
2.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_ALL – Acute lymphocytic leukaemia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).